pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,096 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT825Endpoints628BioPharma Dive239onclive165Fierce Biotech91BioSpace90raps32globenewswire health28fda recalls
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology6Hematology
  • STAT+: Pharmalittle: We’re reading about a Supreme Court hearing on ‘skinny labels,’ AstraZeneca U.K. expansion, and more
    AstraZeneca will resume expansion of its U.K. R&D operations after the trade deal with the U.S. included measures to lift U.K. drug spending
    STAT · 3mo ago↗ source
  • Smog from wildfires increasingly harmful, data show
    American baby formula testing, Medicaid work requirements, and more Morning Rounds health news
    STAT · 3mo ago↗ source
  • STAT+: What does Akeso’s primo plenary spot say about its survival data?
    Mystery cloaks an ASCO plenary lung cancer survival result.
    STAT · 3mo ago↗ source
← prev
page 41 of 44
next →
22
fda press21
fda medwatch17
6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
  • STAT+: New obesity tool aims to predict risk of 18 serious complications
    A new tool, OBSCORE, is meant to better define who's at risk for obesity complications, going beyond BMI to include family history, diet, and more.
    STAT · 3mo ago↗ source
  • Opinion: Are international medical graduates taking residency spots from Americans? We did the math
    A new social media narrative claims international grads are stealing American doctors’ jobs. These authors did the math to figure out if it’s true.
    STAT · 3mo ago↗ source
  • Securing NIH awards is getting more competitive — and confusing
    The likelihood of snagging NIH grants has plunged to historic lows, forcing academic researchers to resort to a variety of tactics to try to obtain funding
    STAT · 3mo ago↗ source
  • Opinion: Congress must hold RFK Jr. accountable after hearings
    Michael Burgess and Larry Bucshon, former Republican congressmen and doctors, weigh in on RFK Jr.’s recent congressional hearings.
    STAT · 3mo ago↗ source
  • Avalyn, in pursuit of better lung drugs, banks $300M in an IPO
    The biotech will use the proceeds to develop inhalable versions of therapies already on the market for the “idiopathic” and “progressive” forms of pulmonary fibrosis.
    BioPharma Dive · 3mo ago↗ source
  • HHS appeals ruling that stalled many of Kennedy’s vaccine policy changes
    The appeal is the latest twist in the closely watched lawsuit filed by the American Association of Pediatrics.
    STAT · 3mo ago↗ source
  • STAT+: Supreme Court justices appear to signal ‘skinny labeling’ can survive
    At Wednesday's argument, the justices did not appear to question whether skinny labeling is valid.
    STAT · 3mo ago↗ source
  • STAT+: Why conversations around health AI may be evolving beyond hype
    In this edition of AI Prognosis, Brittany Trang argues that the tide may be turning when it comes to how the health care industry talks about AI.
    STAT · 3mo ago↗ source
  • Teva nabs experimental Tourette drug in $700M Emalex buyout
    A Jefferies analyst argued the deal — Teva’s largest in a decade — “makes sense” given the synergies between Emalex and the pharmaceutical giant’s neurology business.
    BioPharma Dive · 3mo ago↗ source
  • Chiesi to buy KalVista in $1.9B deal for rare disease drug
    The acquisition is the fifth of a biotech company so far this week and, according to some Wall Street analysts, proves pharma’s interest in new and emerging oral therapies for hereditary angioedema.
    BioPharma Dive · 3mo ago↗ source
  • FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech
    Through two pioneering studies, Amgen and AstraZeneca will share study data with FDA scientists as it’s accrued. Elsewhere, Lilly inked a gene editing deal and Pfizer reported success for a multipl…
    BioPharma Dive · 3mo ago↗ source
  • Infant formula largely safe from heavy metals, FDA finds
    FDA sampled 312 major infant formula brands and found low or undetectable levels of pesticide residue, PFAS, heavy metals and phthalates.
    STAT · 3mo ago↗ source
  • STAT+: A patent win for Pfizer and BridgeBio
    A change to FDA clinical trial data review, Rocket sells its priority review voucher, and more biotech news from The Readout
    STAT · 3mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about the FDA speeding up trials, a Supreme Court hearing on ‘skinny labels,’ and more
    The FDA announced efforts to make clinical trials more efficient, starting by reviewing data in real time from trials conducted by AstraZeneca and Amgen
    STAT · 3mo ago↗ source
  • Food safety experts warn of USDA brain drain
    An autism advisory committee finally meets again, antipsychotics and dementia, and more health news from Morning Rounds
    STAT · 3mo ago↗ source
  • Opinion: Why alternative medicine can feel so much better than mainstream health care
    Modern medicine is about making people better — not necessarily making them feel good.
    STAT · 3mo ago↗ source
  • Opinion: The medical school nutrition blues
    “I don’t think anyone has the answers. But the conversation needs to start”: medical students on bringing a preventive mindset to medical education.
    STAT · 3mo ago↗ source
  • Opinion: STAT+: Did Kennedy just stack the deck on FDA oversight of peptides?
    RFK Jr. had long signaled that he was going to do something big on peptides. Now the moment has arrived.
    STAT · 3mo ago↗ source
  • New report shows some health equity wins. Experts fear they will be short-lived
    A report released Wednesday highlights successes in reducing health disparities in U.S. states between 2022 and 2024.
    STAT · 3mo ago↗ source
  • In first meeting, federal autism committee focuses on ‘profound autism’
    The committee met for the first time since Kennedy fired most of the committee’s scientific experts and replaced them with activists and advocates.
    STAT · 3mo ago↗ source
  • STAT+: Health system CEOs get off easy at Congressional hearing on affordability
    Committee members largely blamed the other party’s health care policies for driving U.S. health care prices to levels inaccessible to many Americans.
    STAT · 3mo ago↗ source
  • STAT+: AIDS group sues Trump administration over undisclosed agreement with Gilead
    The AIDS advocacy group PrEP4All has sued the Trump administration over an undisclosed agreement with Gilead.
    STAT · 3mo ago↗ source